Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection

6 Jun 2018

Abstract excerpt

Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans the biological, physical, and social sciences.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Herpesvirus Infections and Treatments
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29875141
DOI: 10.1073/pnas.1806420115

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protectionPMID 29875141Read ↗

Vaccine vectors: the bright side of cytomegalovirusSemantic proximity Read ↗

Infectious vaccines.Semantic proximity Read ↗

The bacillus Calmette–Guérin vaccination allows the innate immune system to provide protection from severe COVID-19 infectionSemantic proximity Read ↗

Vaccination with a disabled infectious single cycle cytomegalovirus vaccine elicits a distinct glycoprotein B-specific monoclonal antibody repertoire compared to that of naturally-infected individualsSemantic proximity Read ↗

Eliciting B cell immunity against infectious diseases using nanovaccines.Semantic proximity Read ↗

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen designSemantic proximity Read ↗

Vaccines: past, present and futureSemantic proximity Read ↗

CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccinationSemantic proximity Read ↗

Cytomegalovirus: Shape-Shifting the Immune SystemSemantic proximity Read ↗

The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spreadSemantic proximity Read ↗

Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responsesSemantic proximity Read ↗

Designing Recombinant Vaccines with Viral Properties: A Rational Approach to More Effective VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.